ZS ZS is a management consulting & technology firm focused on transforming global healthcare & beyond

ZS research found that the average U.S. wealth asset manager in the study could trace 75% of its own sales to a buying l...
10/30/2026

ZS research found that the average U.S. wealth asset manager in the study could trace 75% of its own sales to a buying location—but that dropped to about 50% when identifying the buying unit or individual adviser.

Not every decision requires the same level of certainty. Compensation and performance management may demand line-item accuracy, while marketing, product development, forecasting and AI applications can benefit from directional insight.

See how asset managers can match data certainty to the decisions they need to make: https://www.zs.com/insights/asset-management-data-observability?utm_source=linkedin&utm_medium=social&utm_campaign=asset-management&utm_term=financial-services-20261029

Pharma's next AI challenge isn't proving what AI can do. It's turning that potential into value at scale.That takes more...
10/29/2026

Pharma's next AI challenge isn't proving what AI can do. It's turning that potential into value at scale.

That takes more than adoption. Trusted data, governance, agentic AI and new ways of working will all shape how organizations move from experimentation to enterprise impact.

Explore the priorities shaping what comes next in our latest CDIO Outlook Report: https://www.zs.com/insights/ai-value-in-pharma-cdio-2027?utm_source=facebook&utm_medium=social&utm_campaign=ai-value-in-pharma&utm_term=cdio-20261026&utm_content=static

10/29/2026

What's the future of loyalty programs as AI influences how travelers search and book hotels?

ZS's Peter Manoogian joined Heather Balsley of IHG Hotels & Resorts at Skift Global Forum to talk about this shift and how hotel brands should respond. By creating quality content that is both machine readable and meaningful to the customer, hotels can drive demand and strengthen loyalty.

Watch the full conversation: https://www.youtube.com/watch?v=cCbIQbigN6k

Rethinking your commercial model?Meet with ZS experts at Veeva Systems Commercial Summit Europe to discuss how agentic A...
10/28/2026

Rethinking your commercial model?

Meet with ZS experts at Veeva Systems Commercial Summit Europe to discuss how agentic AI, Vault CRM and smarter customer engagement can help life sciences organizations turn commercial ambition into action.

Join us in Copenhagen Nov. 18-19, 2026 to explore what these shifts could mean for your organization.

Book a meeting with ZS: https://engage.zs.com/veeva-summit-eu-26?utm_source=facebook&utm_medium=social&utm_campaign=veeva-summit-eu-26+&utm_term=pre-event-20261027

10/22/2026

Growing fast? Know what to build now and what can wait.

For emerging biopharma, every investment competes for limited time and capital. Build too little, too late, and you risk a stumbled launch. Build too much, too soon, and you burn resources you can’t get back.

Our Emerging Biopharma Maturity Assessment shows you where your organization stands today and which capabilities will matter most next, so you can move forward with confidence.

Whether you’re gearing up for launch, preparing to commercialize, or accelerating post-launch growth, it takes just a couple of minutes to see what comes next.

Take the assessment and see where you stand →https://zaidyn.zs.com/blogs/emerging-pharma-maturity-assessment?utm_source=facebook&utm_medium=social&utm_campaign=emerging-pharma-maturity-assessment&utm_term=blog-20261022&utm_content=zaidyn-ep

For life sciences teams, more technology doesn't always mean faster results. More tools can bring more configuration, ha...
10/21/2026

For life sciences teams, more technology doesn't always mean faster results. More tools can bring more configuration, handoffs and workarounds.

See how purpose-built, connected applications can reduce friction, give AI trusted context and help commercial and medical teams move from insight to action faster.

Read the article to learn how to shorten the path to value: https://zaidyn.zs.com/blogs/accelerating-time-to-value?utm_source=facebook&utm_medium=social&utm_campaign=accelerating-time-to-value&utm_term=zaidyn-20261016

10/21/2026

Not every platform is built for the realities of life sciences.

Ivan Cadiente, Senior Director, Field and Data Operations, Sobi, shares how ZAIDYN® comes purpose-built for the industry. Life sciences teams can now get up and running faster without complex customization.

See how ZAIDYN helps emerging biopharma companies turn fragmented data into faster, more informed decisions: https://bit.ly/3VqkY0z

Microsoft Fabric and Power BI can help lay the data foundation for agentic AI.Fragmented dashboards, conflicting busines...
10/21/2026

Microsoft Fabric and Power BI can help lay the data foundation for agentic AI.

Fragmented dashboards, conflicting business logic and inconsistent metrics can undermine the reliability of the data agents depend on. Modernizing legacy BI can help create a trusted, governed source of truth for the next generation of AI applications.

Explore how ZS is helping organizations get more value from their data in Technology Record: https://www.technologyrecord.com/digital/magazine/issue42/76/

Where is biopharma investment headed, and how can healthcare leaders position their organizations for long-term success?...
10/20/2026

Where is biopharma investment headed, and how can healthcare leaders position their organizations for long-term success?

Join ZS at Jefferies Global Healthcare Conference in London, November 16-19, where Principals Cody Powers and Romain Bonnot will connect with industry leaders to discuss investment trends, strategic partnerships and the evolving healthcare landscape.

Interested in connecting? Learn more about our executive panel and reception: https://engage.zs.com/zsjefferies?utm_source=facebook&utm_medium=social&utm_campaign=zsjefferies&utm_term=static-1post-20261020

10/19/2026

Do you know the 40/40/20 rule for scaling AI in pharma R&D?

Moving beyond AI pilots takes more than the right technology. It requires the data, knowledge and workflow changes needed to turn AI capabilities into real enterprise value.

Explore how R&D leaders can scale AI beyond the pilot stage: https://www.zs.com/insights/how-pharma-r-and-d-can-scale-ai-and-deliver-growth?utm_source=facebook&utm_medium=social&utm_campaign=how-pharma-r-and-d-can-scale-ai-and-deliver-growth&utm_term=video-20261019

Address

Evanston, IL

Telephone

+18474923600

Alerts

Be the first to know and let us send you an email when ZS posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to ZS:

Share

Nearby computer & electronics services